Rowley Law PLLC is investigating potential claims against NxStage Medical, Inc. (NASDAQ: NXTM) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Fresenius Medical Care for $30.00 per share in cash. The transaction is valued at approximately $2 billion and is expected to close in 2018.
If you are a NxStage Medical, Inc. shareholder and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Danielle Rowland Lindahl, Esq. at Rowley Law PLLC, 2316 Rhode Island Ave NE, Washington, DC 20018, by email at [email protected], or by telephone at 202-800-3501 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Request Information
The submission of this form does not create an attorney-client relationship.